Of note, two leiomyosarcoma patients enrolled in the aforementioned trial10 received additional treatments with docetaxel or radiotherapy, both of which might promote ICD and cause an elevation of circulating HMGB1 concentrations. This evidence concerns the gene HMGB1 and leiomyosarcoma.